Adam J. Belanger

1.4k total citations
25 papers, 1.2k citations indexed

About

Adam J. Belanger is a scholar working on Molecular Biology, Cancer Research and Immunology and Allergy. According to data from OpenAlex, Adam J. Belanger has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Immunology and Allergy. Recurrent topics in Adam J. Belanger's work include Cancer, Hypoxia, and Metabolism (10 papers), Cell Adhesion Molecules Research (7 papers) and Angiogenesis and VEGF in Cancer (4 papers). Adam J. Belanger is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Cell Adhesion Molecules Research (7 papers) and Angiogenesis and VEGF in Cancer (4 papers). Adam J. Belanger collaborates with scholars based in United States, Japan and France. Adam J. Belanger's co-authors include Canwen Jiang, Richard J. Gregory, Seng H. Cheng, Karen A. Vincent, Taro Date, Geoffrey Y. Akita, Midori Yamakawa, Tamar Tennenbaum, Stuart H. Yuspa and Takayuki Kuriyama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation Research.

In The Last Decade

Adam J. Belanger

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam J. Belanger United States 17 594 433 172 145 131 25 1.2k
Ariane Galaup France 15 667 1.1× 372 0.9× 343 2.0× 141 1.0× 142 1.1× 17 1.3k
Isao Inoki Japan 13 862 1.5× 303 0.7× 118 0.7× 187 1.3× 147 1.1× 19 1.4k
Krystyna Teichert-Kuliszewska Canada 14 711 1.2× 196 0.5× 262 1.5× 125 0.9× 110 0.8× 25 1.4k
Ayman Al Haj Zen United Kingdom 23 722 1.2× 253 0.6× 184 1.1× 119 0.8× 103 0.8× 37 1.6k
Virginie Mattot France 22 1.1k 1.9× 455 1.1× 85 0.5× 143 1.0× 142 1.1× 35 1.7k
Richard Magid United States 10 375 0.6× 438 1.0× 189 1.1× 69 0.5× 124 0.9× 10 1.1k
Hideyasu Oh Japan 25 1.2k 2.1× 282 0.7× 297 1.7× 104 0.7× 75 0.6× 45 2.8k
Laura A. Maile United States 28 874 1.5× 307 0.7× 131 0.8× 132 0.9× 306 2.3× 48 1.5k
Annalisa Antonini Italy 14 674 1.1× 433 1.0× 60 0.3× 94 0.6× 144 1.1× 19 1.2k
Noël Lamandé France 21 865 1.5× 296 0.7× 394 2.3× 104 0.7× 53 0.4× 38 1.6k

Countries citing papers authored by Adam J. Belanger

Since Specialization
Citations

This map shows the geographic impact of Adam J. Belanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam J. Belanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam J. Belanger more than expected).

Fields of papers citing papers by Adam J. Belanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam J. Belanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam J. Belanger. The network helps show where Adam J. Belanger may publish in the future.

Co-authorship network of co-authors of Adam J. Belanger

This figure shows the co-authorship network connecting the top 25 collaborators of Adam J. Belanger. A scholar is included among the top collaborators of Adam J. Belanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam J. Belanger. Adam J. Belanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belanger, Adam J., et al.. (2025). HDAC7 influences ER-⍺ transcription via NCoR-HDAC3 dissociation. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1873(5). 141083–141083. 1 indexed citations
2.
Ding, Shi-Ying, Kimberly R. Long, Joseph J. Lucas, et al.. (2024). Targeted Delivery of Small Interfering RNA (siRNA) to Proximal Tubule Cells in the Kidneys. Journal of the American Society of Nephrology. 35(10S). 1 indexed citations
3.
Belanger, Adam J., et al.. (2022). Excretion of excess nitrogen and increased survival by loss of SLC6A19 in a mouse model of ornithine transcarbamylase deficiency. Journal of Inherited Metabolic Disease. 46(1). 55–65. 5 indexed citations
4.
5.
Leger, Andrew J., Adam J. Belanger, Antonius Song, et al.. (2010). Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine. Journal of Bone and Mineral Metabolism. 28(5). 510–519. 32 indexed citations
6.
Luo, Zhengyu, Adam J. Belanger, Karen A. Vincent, et al.. (2009). A hypoxic inducible factor‐1α hybrid enhances collateral development and reduces vascular leakage in diabetic rats. The Journal of Gene Medicine. 11(5). 390–400. 21 indexed citations
7.
Belanger, Adam J., Zhengyu Luo, Karen A. Vincent, et al.. (2007). Hypoxia-inducible factor 1 mediates hypoxia-induced cardiomyocyte lipid accumulation by reducing the DNA binding activity of peroxisome proliferator-activated receptor α/retinoid X receptor. Biochemical and Biophysical Research Communications. 364(3). 567–572. 68 indexed citations
8.
Luo, Yuxia, Canwen Jiang, Adam J. Belanger, et al.. (2006). A Constitutively Active Hypoxia-Inducible Factor-1α/VP16 Hybrid Factor Activates Expression of the Human B-Type Natriuretic Peptide Gene. Molecular Pharmacology. 69(6). 1953–1962. 36 indexed citations
9.
Yamakawa, Midori, Adam J. Belanger, Taro Date, et al.. (2004). Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis. American Journal of Physiology-Renal Physiology. 287(4). F649–F657. 45 indexed citations
10.
Date, Taro, Seibu Mochizuki, Adam J. Belanger, et al.. (2004). Expression of constitutively stable hybrid hypoxia-inducible factor-1α protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury. American Journal of Physiology-Cell Physiology. 288(2). C314–C320. 85 indexed citations
11.
Date, Taro, Zhengyu Luo, Midori Yamakawa, et al.. (2003). Myocardial Expression of Baculoviral p35 Alleviates Doxorubicin-Induced Cardiomyopathy in Rats. Human Gene Therapy. 14(10). 947–957. 6 indexed citations
12.
Jiang, Canwen, Hsienwie Lu, Karen A. Vincent, et al.. (2002). Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1α. Physiological Genomics. 8(1). 23–32. 48 indexed citations
13.
Lu, Hsienwie, Yuxia Luo, Taro Date, et al.. (2002). Stabilization of Vascular Endothelial Growth Factor mRNA by Hypoxia-Inducible Factor 1. Biochemical and Biophysical Research Communications. 291(4). 908–914. 115 indexed citations
14.
Belanger, Adam J., Hsienwie Lu, Taro Date, et al.. (2002). Hypoxia Up-regulates Expression of Peroxisome Proliferator-activated Receptor γ Angiopoietin-related Gene (PGAR) in Cardiomyocytes: Role of Hypoxia Inducible Factor 1α. Journal of Molecular and Cellular Cardiology. 34(7). 765–774. 116 indexed citations
15.
Belanger, Adam J.. (2001). Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: therapeutic implications of fratricidal mode of action. Cardiovascular Research. 51(4). 749–761. 16 indexed citations
16.
Luo, Zhengyu, Maria Palasis, Hsienwie Lu, et al.. (2001). Enhancement of Fas Ligand-Induced Inhibition of Neointimal Formation in Rabbit Femoral and Iliac Arteries by Coexpression of p35. Human Gene Therapy. 12(18). 2191–2202. 16 indexed citations
17.
Qiu, Huawei, et al.. (1998). Homodimerization Restores Biological Activity to an Inactive Erythropoietin Mutant. Journal of Biological Chemistry. 273(18). 11173–11176. 29 indexed citations
18.
Tennenbaum, Tamar, et al.. (1996). Selective changes in laminin adhesion and alpha 6 beta 4 integrin regulation are associated with the initial steps in keratinocyte maturation.. PubMed. 7(5). 615–28. 53 indexed citations
19.
Tennenbaum, Tamar, Adam J. Belanger, Adam B. Glick, et al.. (1995). A splice variant of alpha 6 integrin is associated with malignant conversion in mouse skin tumorigenesis.. Proceedings of the National Academy of Sciences. 92(15). 7041–7045. 27 indexed citations
20.
Tennenbaum, Tamar, et al.. (1993). The suprabasal expression of a6β4 integrin predicts a high risk for malignant progression in mouse skin carcinogenesis. Journal of Dermatological Science. 6(1). 8–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ariane Galaup Breakdown of academic impact, for papers by Isao Inoki Breakdown of academic impact, for papers by Krystyna Teichert-Kuliszewska Breakdown of academic impact, for papers by Ayman Al Haj Zen Breakdown of academic impact, for papers by Virginie Mattot Breakdown of academic impact, for papers by Richard Magid Breakdown of academic impact, for papers by Hideyasu Oh Breakdown of academic impact, for papers by Laura A. Maile Breakdown of academic impact, for papers by Annalisa Antonini Breakdown of academic impact, for papers by Noël Lamandé
Rankless by CCL
2026